People who stop taking GLP-1 medications like Ozempic and Wegovy started to regain weight in a short amount of time, ...

Experts say there’s no evidence GLP-1s can be absorbed through the skin — and these patches don’t contain the FDA-approved ...

Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

Restaurants are creating Ozempic menus with smaller meals for people who are taking GLP-1 weight-loss drugs and have a ...

GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for ...

Discover how food brands can adapt to the rising GLP-1 trend. As weight-loss drugs reshape consumer habits, learn which ...

Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...

More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...

The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide ...

While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...

Low rates of retained gastric contents were seen in endoscopy patients on GLP-1 receptor agonists ( RAs), a retrospective ...